Dia-Präsentation von SERVIER EUROPA-Studie (Perindopril) (60 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken) | ||||||||||||||||||
Abbildung 57: EUROPA-Studie - HOPE-Studie At a mean follow-up of 4.5 years, HOPE reported a placebo mortality of 12%, cardiovascular mortality of 8 %, and Q-wave myocardial infarction of 3 %, compared with 7 %, 4 %, and 2 %, respectively, in EUROPA study at 4.2 years of follow-up. Thus, the major annual event rates in HOPE were 40 % to 80 % higher than those in EUROPA. |
Abbildung 57: EUROPA-Studie - HOPE-Studie
At a mean follow-up of 4.5 years, HOPE reported a placebo mortality of 12%, cardiovascular mortality of 8 %, and Q-wave myocardial infarction of 3 %, compared with 7 %, 4 %, and 2 %, respectively, in EUROPA study at 4.2 years of follow-up. Thus, the major annual event rates in HOPE were 40 % to 80 % higher than those in EUROPA. |
